Denali Therapeutics Inc (DNLI)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$13.56
Buy
$16.05
$0.35 (+2.51%)
Prices updated at 07 May 2025, 23:05 EDT
| Prices minimum 15 mins delay
Prices in USD
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
| Forecast date | |
|---|---|
| Annual report | Feb 2026 |
| Final results | Feb 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | May 2025 |
| Previous date | |
|---|---|
| Annual report | Feb 2025 |
| Final results | Feb 2025 |
| Half yearly results | Aug 2024 |
| Annual general meeting | May 2024 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report 